![](/img/cover-not-exists.png)
HannaH phase III randomised study: Association of total pathological complete response with event-free survival in HER2-positive early breast cancer treated with neoadjuvant–adjuvant trastuzumab after 2 years of treatment-free follow-up
Jackisch, Christian, Hegg, Roberto, Stroyakovskiy, Daniil, Ahn, Jin-Seok, Melichar, Bohuslav, Chen, Shin-Cheh, Kim, Sung-Bae, Lichinitser, Mikhail, Starosławska, Elżbieta, Kunz, Georg, Falcon, Silvia,Volume:
62
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2016.03.087
Date:
July, 2016
File:
PDF, 782 KB
english, 2016